Duopharma Biotech Bhd
KLSE:DPHARMA
Duopharma Biotech Bhd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.13
1.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Duopharma Biotech Bhd hold over its rivals?
What risks and challenges
does Duopharma Biotech Bhd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Duopharma Biotech Bhd.
Provide an overview of the primary business activities
of Duopharma Biotech Bhd.
What unique competitive advantages
does Duopharma Biotech Bhd hold over its rivals?
What risks and challenges
does Duopharma Biotech Bhd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Duopharma Biotech Bhd.
Provide P/S
for Duopharma Biotech Bhd.
Provide P/E
for Duopharma Biotech Bhd.
Provide P/OCF
for Duopharma Biotech Bhd.
Provide P/FCFE
for Duopharma Biotech Bhd.
Provide P/B
for Duopharma Biotech Bhd.
Provide EV/S
for Duopharma Biotech Bhd.
Provide EV/GP
for Duopharma Biotech Bhd.
Provide EV/EBITDA
for Duopharma Biotech Bhd.
Provide EV/EBIT
for Duopharma Biotech Bhd.
Provide EV/OCF
for Duopharma Biotech Bhd.
Provide EV/FCFF
for Duopharma Biotech Bhd.
Provide EV/IC
for Duopharma Biotech Bhd.
Show me price targets
for Duopharma Biotech Bhd made by professional analysts.
What are the Revenue projections
for Duopharma Biotech Bhd?
How accurate were the past Revenue estimates
for Duopharma Biotech Bhd?
What are the Net Income projections
for Duopharma Biotech Bhd?
How accurate were the past Net Income estimates
for Duopharma Biotech Bhd?
What are the EPS projections
for Duopharma Biotech Bhd?
How accurate were the past EPS estimates
for Duopharma Biotech Bhd?
What are the EBIT projections
for Duopharma Biotech Bhd?
How accurate were the past EBIT estimates
for Duopharma Biotech Bhd?
Compare the revenue forecasts
for Duopharma Biotech Bhd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Duopharma Biotech Bhd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Duopharma Biotech Bhd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Duopharma Biotech Bhd compared to its peers.
Compare the P/E ratios
of Duopharma Biotech Bhd against its peers.
Discuss the investment returns and shareholder value creation
comparing Duopharma Biotech Bhd with its peers.
Analyze the financial leverage
of Duopharma Biotech Bhd compared to its main competitors.
Show all profitability ratios
for Duopharma Biotech Bhd.
Provide ROE
for Duopharma Biotech Bhd.
Provide ROA
for Duopharma Biotech Bhd.
Provide ROIC
for Duopharma Biotech Bhd.
Provide ROCE
for Duopharma Biotech Bhd.
Provide Gross Margin
for Duopharma Biotech Bhd.
Provide Operating Margin
for Duopharma Biotech Bhd.
Provide Net Margin
for Duopharma Biotech Bhd.
Provide FCF Margin
for Duopharma Biotech Bhd.
Show all solvency ratios
for Duopharma Biotech Bhd.
Provide D/E Ratio
for Duopharma Biotech Bhd.
Provide D/A Ratio
for Duopharma Biotech Bhd.
Provide Interest Coverage Ratio
for Duopharma Biotech Bhd.
Provide Altman Z-Score Ratio
for Duopharma Biotech Bhd.
Provide Quick Ratio
for Duopharma Biotech Bhd.
Provide Current Ratio
for Duopharma Biotech Bhd.
Provide Cash Ratio
for Duopharma Biotech Bhd.
What is the historical Revenue growth
over the last 5 years for Duopharma Biotech Bhd?
What is the historical Net Income growth
over the last 5 years for Duopharma Biotech Bhd?
What is the current Free Cash Flow
of Duopharma Biotech Bhd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Duopharma Biotech Bhd.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
MY |
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
1.2B MYR | 1.5 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD | 17.3 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD | 4.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 7.2 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF | 4 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP | 4.2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD | 3.5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF | 4.4 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 72.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
MY |
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Average P/S:
63.6
1.5
|
11%
|
0.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.3
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.4
|
3%
|
1.5 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.2
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
4
|
5%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.2
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.5
|
5%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
72.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
0%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.